rs7505
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_014210.4(EVI2A):c.*469C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.501 in 152,988 control chromosomes in the GnomAD database, including 20,966 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.50 ( 20794 hom., cov: 32)
Exomes 𝑓: 0.54 ( 172 hom. )
Consequence
EVI2A
NM_014210.4 3_prime_UTR
NM_014210.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 2.43
Publications
15 publications found
Genes affected
EVI2A (HGNC:3499): (ecotropic viral integration site 2A) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
NF1 Gene-Disease associations (from GenCC):
- neurofibromatosis type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
- neurofibromatosis-Noonan syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
- Moyamoya diseaseInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.615 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EVI2A | NM_014210.4 | c.*469C>T | 3_prime_UTR_variant | Exon 2 of 2 | ENST00000462804.3 | NP_055025.2 | ||
| NF1 | NM_001042492.3 | c.4836-7986G>A | intron_variant | Intron 36 of 57 | ENST00000358273.9 | NP_001035957.1 | ||
| EVI2A | NM_001003927.3 | c.*469C>T | 3_prime_UTR_variant | Exon 3 of 3 | NP_001003927.1 | |||
| NF1 | NM_000267.4 | c.4773-7986G>A | intron_variant | Intron 35 of 56 | NP_000258.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EVI2A | ENST00000462804.3 | c.*469C>T | 3_prime_UTR_variant | Exon 2 of 2 | 1 | NM_014210.4 | ENSP00000420557.3 | |||
| NF1 | ENST00000358273.9 | c.4836-7986G>A | intron_variant | Intron 36 of 57 | 1 | NM_001042492.3 | ENSP00000351015.4 | |||
| ENSG00000265118 | ENST00000578584.5 | c.478+474C>T | intron_variant | Intron 1 of 2 | 2 | ENSP00000463981.2 |
Frequencies
GnomAD3 genomes AF: 0.501 AC: 76012AN: 151788Hom.: 20786 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
76012
AN:
151788
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.538 AC: 582AN: 1082Hom.: 172 Cov.: 0 AF XY: 0.534 AC XY: 314AN XY: 588 show subpopulations
GnomAD4 exome
AF:
AC:
582
AN:
1082
Hom.:
Cov.:
0
AF XY:
AC XY:
314
AN XY:
588
show subpopulations
African (AFR)
AF:
AC:
2
AN:
12
American (AMR)
AF:
AC:
26
AN:
70
Ashkenazi Jewish (ASJ)
AF:
AC:
11
AN:
16
East Asian (EAS)
AF:
AC:
2
AN:
8
South Asian (SAS)
AF:
AC:
88
AN:
168
European-Finnish (FIN)
AF:
AC:
10
AN:
18
Middle Eastern (MID)
AF:
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
AC:
427
AN:
750
Other (OTH)
AF:
AC:
16
AN:
38
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
12
23
35
46
58
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.501 AC: 76045AN: 151906Hom.: 20794 Cov.: 32 AF XY: 0.498 AC XY: 36981AN XY: 74242 show subpopulations
GnomAD4 genome
AF:
AC:
76045
AN:
151906
Hom.:
Cov.:
32
AF XY:
AC XY:
36981
AN XY:
74242
show subpopulations
African (AFR)
AF:
AC:
11905
AN:
41442
American (AMR)
AF:
AC:
6783
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
AC:
2373
AN:
3470
East Asian (EAS)
AF:
AC:
1858
AN:
5164
South Asian (SAS)
AF:
AC:
2736
AN:
4818
European-Finnish (FIN)
AF:
AC:
6337
AN:
10528
Middle Eastern (MID)
AF:
AC:
176
AN:
292
European-Non Finnish (NFE)
AF:
AC:
42144
AN:
67924
Other (OTH)
AF:
AC:
1116
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1800
3601
5401
7202
9002
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
672
1344
2016
2688
3360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.